Table 2.
Gender | Age Range | Therapy (No of Patients) | ALT | AST | Viral Load IU/mL |
---|---|---|---|---|---|
Female 14 (35%) Male 26 (65%) |
10–65 | Entecavir (09) Lamivudine + tenofovir (11) Lamivudine + entecavir (6) Tenofovir (08) Adefovir (06) |
Mean ± SD 73.77 ± 10.43 Median 73.12 Range 56–95 |
Mean 71.03 ± 9.10 Median 70.52 Range 52–93 |
3.0 × 104 to 5.6 × 107 |
Abbreviation: SD: standard deviation, ALT: Alanine transaminase, AST: Asparagine transaminase.